It is a pleasure for KeMyth Biotech to introduce our platform technology and products as follows. Please join our booth for the details in Taiwan Healthcare+ Expo 2019.
(1) Rapid diagnostic kit: KeMyth product, Klebsiella pneumoniae serotype K1/K2 rapid testing cassette (Taiwan FDA License No.007019), has been used by medical centers in Taiwan, published in leading journals (2016, J Clin Microbiol 54, 3018-3021; 2019, Gut Pathog, 11:11), and earned the 13th National Innovation Award in Taiwan.
(2) Platform technology: KeMyth product, antibiotic testing and screening system against superbugs, has been published in a leading journal (2017, J Antimicrob Chemother 72, 3302-16) and has been used by pharmaceutical companies in USA, France or Japan.
(3) Drug development: a candidate drug to control type 2 diabetes, atherosclerosis, and body weight. The U.S. patent number is 10,287,328 B2.
(4) Natural food: Exquisite Ginger Tea; Natural Capsules.
(5) Skin care: Purifying Hydration Mask.
1. Klebsiella pneumoniae serotype K1/K2 rapid testing cassette
2. Antibiotic testing and screening system
3. Diabetes candidate drug
4. Natural food: Exquisite Ginger Tea; Natural Capsules.
5. Skin care: Purifying Hydration Mask.